Psychological processing of a kidney transplantation, perceived quality of life, and immunosuppressant medication adherence

Figures & data

Table 1 Comparison of TxEQ subscale scores by sex

TxEQ subscales		Females (n=93)	Males (n=174)	p (Mann–Whitney U test)	Effect size (r)
Worry	M ± SD (range)	2.9±0.8 (1.3–4.7)	2.8±0.8 (01.0–4.7)	Not significant	0.1
Guilt	M ± SD (range)	2.0±0.6 (1.0–3.4)	1.9±0.7 (1.0–4.0)	Not significant	0.1
Disclosure	M ± SD (range)	4.4±0.7 (2.3–5.0)	4.4±0.7 (1.7–5.0)	Not significant	0.0
Responsibility	M ± SD (range)	2.7±1.0 (1.0–4.5)	2.9±1.1 (1.0–5.0)	Not significant	−0.1
Adherence	M ± SD (range)	4.4±0.6 (2.0–5.0)	4.4±0.6 (1.6–5.0)	Not significant	0.0

Abbreviations: M, mean; SD, Standard Deviation; TxEQ, Transplant Effects Questionnaire.

Table 2 Descriptive data of the TxEQ subscales and their correlative associations

			TxEQ subscales
			Worry	Guilt	Disclosure	Responsibility	Adherence
TxEQ subscales
Worry	M ± SD (range)	2.8±0.8 (1.0–4.7)		0.4**	−0.3**	0.5**	−0.1
Guilt	M ± SD (range)	1.9±0.7 (1.0–4.0)			−0.3**	0.5**	−0.2**
Disclosure	M ± SD (range)	4.4±0.7 (1.7–5.0)				−0.2**	0.3**
Responsibility	M ± SD (range)	2.8±1.0 (1.0–5.0)					−0.1
Adherence	M ± SD (range)	4.4±0.6 (1.6–5.0)

Notes: **p≤0.001; *p<0.05.

Abbreviations: M, mean; SD, Standard Deviation; TxEQ, Transplant Effects Questionnaire.

Table 3 Descriptive data of perceived health-related quality of life, self-reported immunosuppressant medication nonadherence, and sub-therapeutic immunosuppressant trough levels and their correlative associations with the TxEQ subscales

			TxEQ subscales
			Worry	Guilt	Disclosure	Responsibility	Adherence
Immunosuppressant medication variables
Nonadherence (BAASIS©), dichotomous	Yes: n, %	87 (33.3%)	0.0	0.0	−0.0	−0.1	−0.4**
Nonadherence (BAASIS©), continuous	M ± SD (range)	0.6±1.1 (0.0–6.0)	0.0	0.0	−0.1	−0.1	−0.4**
Percentage of sub-therapeutic immunosuppressant trough levels	M ± SD (range)	40±30% (0–100)	0.1*	0.1	−0.1	0.1	0.0
Perceived health-related quality of life
Physical health-related quality of life(SF-12, PCS)	M ± SD (range)	44.9±10.6 (15.7–67.7)	−0.1	−0.1	0.1	−0.0	−0.0
Mental health-related quality of life (SF12, MCS)	M ± SD (range)	49.3±10.2 (19.6–66.5)	−0.3**	−0.3**	0.3**	−0.1*	0.1

Notes: **p≤0.001; *p<0.05.

Abbreviations: M, mean; SD, Standard Deviation; TxEQ, Transplant Effects Questionnaire.

Data availability

The authors have full control of all primary data and agree to allow the journal to review their data if requested.